Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Potential Effect of Immunotherapy Agents on Cognitive Function in Cancer Patients
Florence Joly, Hélène Castel, Laure Tron, et al.
JNCI Journal of the National Cancer Institute (2019) Vol. 112, Iss. 2, pp. 123-127
Open Access | Times Cited: 59

Showing 1-25 of 59 citing articles:

Immune-related adverse events of checkpoint inhibitors
Manuel Ramos‐Casals, Julie R. Brahmer, Margaret K. Callahan, et al.
Nature Reviews Disease Primers (2020) Vol. 6, Iss. 1
Open Access | Times Cited: 1004
Cancer-related cognitive impairment: an update on state of the art, detection, and management strategies in cancer survivors
Marie Lange, Florence Joly, Janette Vardy, et al.
Annals of Oncology (2019) Vol. 30, Iss. 12, pp. 1925-1940
Open Access | Times Cited: 484
Radiation-induced brain injury: current concepts and therapeutic strategies targeting neuroinflammation
Casmir Turnquist, Brent T. Harris, Curtis C. Harris
Neuro-Oncology Advances (2020) Vol. 2, Iss. 1
Open Access | Times Cited: 147
6th and 7th International consensus guidelines for the management of advanced breast cancer (ABC guidelines 6 and 7)
Fátima Cardoso, Shani Paluch‐Shimon, Eva Schumacher-Wulf, et al.
The Breast (2024) Vol. 76, pp. 103756-103756
Open Access | Times Cited: 34
Cancer-related cognitive impairment in patients with non-central nervous system malignancies: an overview for oncology providers from the MASCC Neurological Complications Study Group
Samantha Mayo, Maryam B. Lustberg, Haryana M. Dhillon, et al.
Supportive Care in Cancer (2020) Vol. 29, Iss. 6, pp. 2821-2840
Closed Access | Times Cited: 108
Long-Term Cognitive Dysfunction in Cancer Survivors
Zuzana Országhová, Michal Mego, Michal Chovanec
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 102
Concentrations of S100B and neurofilament light chain in blood as biomarkers for checkpoint inhibitor–induced CNS inflammation
Sara Bjursten, Zhiyuan Zhao, Hifaa Al Remawi, et al.
EBioMedicine (2024) Vol. 100, pp. 104955-104955
Open Access | Times Cited: 13
Cancer-related accelerated ageing and biobehavioural modifiers: a framework for research and clinical care
Judith Carroll, Julienne E. Bower, Patricia A. Ganz
Nature Reviews Clinical Oncology (2021) Vol. 19, Iss. 3, pp. 173-187
Open Access | Times Cited: 55
Cognitive impairment following breast cancer treatments: an umbrella review
Giulia Oliva, Andreina Giustiniani, Laura Danesin, et al.
The Oncologist (2024) Vol. 29, Iss. 7, pp. e848-e863
Open Access | Times Cited: 7
Cognitive Function in Older Adults With Cancer: Assessment, Management, and Research Opportunities
Allison Magnuson, Tim A. Ahles, Bihong T. Chen, et al.
Journal of Clinical Oncology (2021) Vol. 39, Iss. 19, pp. 2138-2149
Open Access | Times Cited: 40
Change in Patients’ Perceived Cognition Following Chimeric Antigen Receptor T-Cell Therapy for Lymphoma
Anna Barata, Aasha I. Hoogland, Anuhya Kommalapati, et al.
Transplantation and Cellular Therapy (2022) Vol. 28, Iss. 7, pp. 401.e1-401.e7
Open Access | Times Cited: 26
Expanded taxonomies of human memory
Jason R. Finley
Frontiers in Cognition (2025) Vol. 3
Open Access
Immune checkpoint inhibitors and cancer-related cognitive decline: a propensity score matched analysis in active chemotherapy patients
Guangmin Jian, Jiling Zeng, Jun Lü, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Screening for cognitive impairment in routine clinical oncology practice: a pilot study using patient-reported outcome measures and online cognitive testing in melanoma and breast cancer patients
Elaine A.C. Albers, Kelly M. de Ligt, Iris M. C. van der Ploeg, et al.
Supportive Care in Cancer (2025) Vol. 33, Iss. 4
Open Access
The tumor organismal environment: Role in tumor development and cancer immunotherapy
Lothar C. Dieterich, Andréas Bikfalvi
Seminars in Cancer Biology (2019) Vol. 65, pp. 197-206
Open Access | Times Cited: 38
A Systematic Review on the Potential Acceleration of Neurocognitive Aging in Older Cancer Survivors
Charlotte Kerstens, Hans Wildiers, Gwen Schroyen, et al.
Cancers (2023) Vol. 15, Iss. 4, pp. 1215-1215
Open Access | Times Cited: 12
Unveiling Cognitive Impairment in Older Adults with Cancer on Systemic Anticancer Therapy: A Comprehensive Review
Rémi Fernandez, Gemma Fargas Baella, V. Slavova-Boneva, et al.
Drugs & Aging (2025)
Closed Access
Changes of perioperative cognitive function and its effect on quality of life in laryngeal cancer
Zehui Gao, Lina Jia, John Yao, et al.
Perioperative Medicine (2025) Vol. 14, Iss. 1
Open Access
Structural Neuroimaging Findings Related to Adult Non-CNS Cancer and Treatment: Review, Integration, and Implications for Treatment of Cognitive Dysfunction
Brenna C. McDonald
Neurotherapeutics (2021) Vol. 18, Iss. 2, pp. 792-810
Open Access | Times Cited: 26
Cognitive adverse events in patients with lung cancer treated with checkpoint inhibitor monotherapy: a propensity score-matched analysis
Yifei Ma, Nianqi Liu, Yanqi Wang, et al.
EClinicalMedicine (2023) Vol. 59, pp. 101987-101987
Open Access | Times Cited: 10
Animal models of brain metastasis
Lauritz Miarka, Manuel Valiente
Neuro-Oncology Advances (2021) Vol. 3, Iss. Supplement_5, pp. v144-v156
Open Access | Times Cited: 21
Whole-brain radiotherapy associated with structural changes resembling aging as determined by anatomic surface-based deep learning
Nikhil Ram-Mohan, Alexander Ho, Pierre Besson, et al.
Neuro-Oncology (2023) Vol. 25, Iss. 7, pp. 1323-1330
Open Access | Times Cited: 8
A randomised wait-list controlled trial to evaluate Emotional Freedom Techniques for self-reported cancer-related cognitive impairment in cancer survivors (EMOTICON)
Laura Tack, Tessa Lefebvre, Michelle Lycke, et al.
EClinicalMedicine (2021) Vol. 39, pp. 101081-101081
Open Access | Times Cited: 18
Cancer-related cognitive impairment in non-CNS cancer patients: Targeted review and future action plans in Europe
Charlotte Sleurs, Ali Amidi, Lisa M. Wu, et al.
Critical Reviews in Oncology/Hematology (2022) Vol. 180, pp. 103859-103859
Open Access | Times Cited: 13
Effect of acceptance and commitment therapy‐based interventions on mental health and cognitive impairment for patients with advanced colorectal cancer
Eman Abdeen Ali, Mahmoud Abdelwahab Khedr, Amany Anwar Saeed Alabdullah, et al.
Public Health Nursing (2024) Vol. 41, Iss. 4, pp. 745-759
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top